Literature DB >> 10990200

Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers.

I De Miguel1, L Imbertie, V Rieumajou, M Major, R Kravtzoff, D Betbeder.   

Abstract

PURPOSE: Supramolecular Biovectors (SMBV) consist of cross-linked cationic nanoparticles surrounded by a lipid membrane. The purpose was to study the structure of the lipid membrane and to characterise its interaction with the nanoparticles in order to differentiate SMBV from other polymer/lipid associations.
METHODS: The interaction of lipids with the nanoparticle surface was studied using zeta potential. Fluorescence Energy Transfer (FET) and Fluorescence Microscopy. SMBV were compared to liposomes and mixtures nanoparticles/liposomes. Finally the structure of SMBV was visualised by Electron Microscopy.
RESULTS: Zeta potential measurements showed that lipids on SMBV had a pronounced shielding effect on the surface charge. This was not the case for mixtures of nanoparticles and liposomes. FET experiments confirmed these results indicating that, for SMBV, the lipids are much closer to the nanoparticle surface. SMBV Fluorescence microscopy on model microparticles showed a lipid crown on SMBV that was confirmed by electron microscopy on SMBV nanoparticles.
CONCLUSIONS: Results show that in case of SMBV lipids are strongly adsorbed on the polysaccharide core surface probably due to ionic/hydrophobic interactions. The resulting supramolecular structure is a spherical cationic polysaccharide particle surrounded by a phospholipid/cholesterol layer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990200     DOI: 10.1023/a:1007504124603

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV).

Authors:  M Berton; S Sixou; R Kravtzoff; C Dartigues; L Imbertie; C Allal; G Favre
Journal:  Biochim Biophys Acta       Date:  1997-01-10

2.  Solid core liposomes with encapsulated colloidal gold particles.

Authors:  K Gao; L Huang
Journal:  Biochim Biophys Acta       Date:  1987-03-12

Review 3.  The surface properties of phospholipid liposome systems and their characterisation.

Authors:  M N Jones
Journal:  Adv Colloid Interface Sci       Date:  1995-01-03       Impact factor: 12.984

4.  Monitoring of phospholipid vesicle fusion by fluorescence energy transfer between membrane-bound dye labels.

Authors:  P Vanderwerf; E F Ullman
Journal:  Biochim Biophys Acta       Date:  1980-02-28

5.  Surface density determination in membranes by fluorescence energy transfer.

Authors:  B K Fung; L Stryer
Journal:  Biochemistry       Date:  1978-11-28       Impact factor: 3.162

6.  Lipobeads: a hydrogel anchored lipid vesicle system.

Authors:  T Jin; P Pennefather; P I Lee
Journal:  FEBS Lett       Date:  1996-11-11       Impact factor: 4.124

7.  Use of resonance energy transfer to monitor membrane fusion.

Authors:  D K Struck; D Hoekstra; R E Pagano
Journal:  Biochemistry       Date:  1981-07-07       Impact factor: 3.162

8.  Characterization and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles.

Authors:  M Major; E Prieur; J F Tocanne; D Betbeder; A M Sautereau
Journal:  Biochim Biophys Acta       Date:  1997-07-05

9.  Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors.

Authors:  N Castignolles; D Betbeder; K Ioualalen; O Merten; C Leclerc; D Samain; P Perrin
Journal:  Vaccine       Date:  1994-11       Impact factor: 3.641

10.  SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression.

Authors:  C Allal; S Sixou; R Kravtzoff; N Soulet; G Soula; G Favre
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more
  13 in total

1.  Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.

Authors:  Warefta Hasan; Kevin Chu; Anuradha Gullapalli; Stuart S Dunn; Elizabeth M Enlow; J Christopher Luft; Shaomin Tian; Mary E Napier; Patrick D Pohlhaus; Jason P Rolland; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-12-21       Impact factor: 11.189

Review 2.  Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review.

Authors:  Rajiv Kumar; Om Prakash Katare
Journal:  AAPS PharmSciTech       Date:  2005-10-06       Impact factor: 3.246

3.  Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing.

Authors:  Pedro M Valencia; Pamela A Basto; Liangfang Zhang; Minsoung Rhee; Robert Langer; Omid C Farokhzad; Rohit Karnik
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

4.  Properties of a self-assembled phospholipid membrane supported on lipobeads.

Authors:  Charlene C Ng; Yu-Ling Cheng; Peter S Pennefather
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 5.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 6.  Membrane mimetic surface functionalization of nanoparticles: methods and applications.

Authors:  Jacob Weingart; Pratima Vabbilisetty; Xue-Long Sun
Journal:  Adv Colloid Interface Sci       Date:  2013-05-02       Impact factor: 12.984

7.  Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers.

Authors:  Archibald Paillard; Catherine Passirani; Patrick Saulnier; Maya Kroubi; Emmanuel Garcion; Jean-Pierre Benoît; Didier Betbeder
Journal:  Pharm Res       Date:  2009-10-23       Impact factor: 4.200

8.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

Authors:  Liangfang Zhang; Juliana M Chan; Frank X Gu; June-Wha Rhee; Andrew Z Wang; Aleksandar F Radovic-Moreno; Frank Alexis; Robert Langer; Omid C Farokhzad
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

9.  Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles.

Authors:  B C Baudner; O Balland; M M Giuliani; P Von Hoegen; R Rappuoli; D Betbeder; G Del Giudice
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.

Authors:  Muhammad Muzamil Khan; Asadullah Madni; Nayab Tahir; Farzana Parveen; Safiullah Khan; Nasrullah Jan; Ahsan Ali; Muhammad Abdurrahim; Umar Farooq; Muhammad Imran Khan
Journal:  Int J Nanomedicine       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.